This session highlights the use of biomaterials in industry and medicine, including but not limited to the following topics: clinical translation, product commercialization, and corporate research and development. Abstracts from companies, non-profit organizations, and regulatory agencies are encouraged, as well as a discussion of the challenges encountered in transforming biomaterial discoveries into viable products. Due to the translational nature of the abstracts being solicited, it is understood that some technical details cannot be disclosed. As a result, it is acceptable for the abstracts (and accepted presentations) to omit certain details for intellectual property reasons. Polymers, ceramics, metals, and all other areas of biomaterials research are welcome. Additional abstracts addressing career transitions and/or opportunities for industrial applications of biomaterials are welcome.
12:30 PM
Elizabeth Aikman, Marisa O. Pacheco, William Gross, Hannah Bagnis, Isabelle Gerzenshtein, Travis Truong, Whitney Stoppel
12:45 PM
Yug Chandra Saraswat, Chenxian Xu, Lilian Hsiao
01:00 PM
Jake Song, Elad Deiss-Yehiely, Serra Yesilata, Gareth H. McKinley
01:15 PM
Santanu Kundu, Mohammad Moinul Hossain
01:30 PM
Joseph Scalet, Jeayoung Jeong, Stevin Gehrke
01:45 PM
Benjamin Beall, Jarred Funderburk, Gabriella Zampini, Nader Taheri-Qazvini
02:00 PM
Mahima Srivastava, Srinivasa R. Raghavan
02:15 PM
02:30 PM
Sungwan Park, Justin Jeongwoo Choi, Silas Lorenz, Albert Liu
02:45 PM
Sarah Sergi, Finlay J. M. Smith, Melissa Gordon